UBS AM’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Buy |
1,210,209
+433,851
| +56% | +$998K | ﹤0.01% | 1993 |
|
|
2025
Q1 | $3.36M | Sell |
776,358
-21,300
| -3% | -$92.2K | ﹤0.01% | 1763 |
|
|
2024
Q4 | $1.52M | Buy |
797,658
+157,610
| +25% | +$299K | ﹤0.01% | 2173 |
|
|
2024
Q3 | $2.52M | Buy |
640,048
+37,725
| +6% | +$148K | ﹤0.01% | 1923 |
|
|
2024
Q2 | $3.94M | Buy |
602,323
+182,209
| +43% | +$1.19M | ﹤0.01% | 1620 |
|
|
2024
Q1 | $2.56M | Sell |
420,114
-77,710
| -16% | -$474K | ﹤0.01% | 1556 |
|
|
2023
Q4 | $6.25M | Buy |
497,824
+36,049
| +8% | +$452K | ﹤0.01% | 1156 |
|
|
2023
Q3 | $8.2M | Buy |
461,775
+151,786
| +49% | +$2.7M | ﹤0.01% | 1017 |
|
|
2023
Q2 | $7.36M | Hold |
309,989
| – | – | ﹤0.01% | 1080 |
|
|
2023
Q1 | $7.36M | Sell |
309,989
-7,101
| -2% | -$169K | ﹤0.01% | 1080 |
|
|
2022
Q4 | $5.12M | Buy |
317,090
+15,626
| +5% | +$252K | ﹤0.01% | 1166 |
|
|
2022
Q3 | $7.06M | Buy |
301,464
+35,905
| +14% | +$841K | ﹤0.01% | 1083 |
|
|
2022
Q2 | $5.8M | Buy |
265,559
+187,046
| +238% | +$4.08M | ﹤0.01% | 1165 |
|
|
2022
Q1 | $1.99M | Hold |
78,513
| – | – | ﹤0.01% | 1801 |
|
|
2021
Q4 | $2.12M | Buy |
78,513
+52,354
| +200% | +$1.41M | ﹤0.01% | 1850 |
|
|
2021
Q3 | $686K | Hold |
26,159
| – | – | ﹤0.01% | 2346 |
|
|
2021
Q2 | $1.06M | Buy |
+26,159
| New | +$1.06M | ﹤0.01% | 2174 |
|